{name}
{subtitle}
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
city
~9 mi. (Altoona, Pennsylvania, +469 more cities)
facility
UPMC Altoona
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
city
~9 mi. (Altoona, Pennsylvania, +224 more cities)
facility
UPMC Altoona
condition
Hypopharyngeal Carcinoma, +3 more conditions
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +3 more types
Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer
city
~9 mi. (Altoona, Pennsylvania, +142 more cities)
facility
UPMC Altoona
drug
apalutamide, +2 more drugs
drug type
hormone therapy, +1 more type
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
city
~37 mi. (State College, Pennsylvania, +822 more cities)
facility
Geisinger Medical Group, +1 more facility
biomarker
ER Negative, +2 more biomarkers
drug
carboplatin, +3 more drugs
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~37 mi. (State College, Pennsylvania, +954 more cities)
facility
Geisinger Medical Group
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types